Results 211 to 220 of about 427,029 (392)
Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia [PDF]
Jerald P. Radich
openalex +1 more source
What's new? Mitogen‐activated protein kinase (MAPK) inhibitors are promising treatments for pediatric Langerhans cell histiocytosis (LCH), a rare heterogeneous neoplasm that often affects multiple organ systems. Which MAPK inhibitors are most effective against LCH remains uncertain.
Xue Tang +5 more
wiley +1 more source
HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma
What's New? Ovarian clear cell carcinoma is highly associated with hypoxia. Hypoxia‐inducible factor 2A (HIF2A) is a key regulator of hypoxic responses, but its role in ovarian clear cell carcinoma remains unclear. This study demonstrated the unfavorable prognostic significance of HIF2A expression in ovarian clear cell carcinoma.
Mengxin Jiang +15 more
wiley +1 more source
Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia. [PDF]
Yaman F +6 more
europepmc +1 more source
Constitutional C-band polymorphism in lymphocytes from patients with chronic myeloid leukemia [PDF]
Ulf Kristoffersson +6 more
openalex +1 more source
What's New? The 1986 Chernobyl accident led to widespread radioactive contamination across parts of Europe, with elevated childhood leukaemia rates observed in heavily affected areas of Ukraine. Data on long‐term haematological and other non‐thyroid cancer risk in the general population in heavily contaminated regions, however, remain limited.
Ljubica Zupunski +10 more
wiley +1 more source
Chronic Myeloid Leukemia and the T315I <i>BCR::ABL1</i> Mutation. [PDF]
Pierro F +8 more
europepmc +1 more source
Abstract Background and Objectives Children with medical complexity (CMC) have chronic health conditions often associated with functional limitations. CMC comprise 1%–5% of the pediatric population. In Canada, their care accounts for one‐third of pediatric health spending.
Erin Hessey +25 more
wiley +1 more source
Management of chronic myeloid leukemia in 2025. [PDF]
Kantarjian H +9 more
europepmc +1 more source

